Associated factors with functional disability and health-related quality of life in Chinese patients with gout: a case-control study

Table 6 Stepwise multiple linear regression analysis of SF-36 domains in gout patients

	β	SE	t	P	B (95% CI)		F	Adj R²
	β	SE	t	P	Lower	Upper	F	Adj R²
PCS							15.779	0.247
Depression (PHQ-9 ≥ 10 score)	−16.649	3.693	−4.508	<0.001	−23.928	−9.370
Total pain (VAS)	−1.551	.372	−4.165	<0.001	−2.285	−0.817
Cardiovascular disease	−12.562	4.342	−2.894	0.004	−21.119	−4.006
Number of flares/last year	−0.129	0.058	−2.226	0.027	−0.244	−0.015
Colchicine	−5.772	2.666	−2.165	0.031	−11.026	−0.518
MCS							14.686	0.267
Depression (PHQ-9 ≥ 10 score)	−14.268	3.967	−3.596	<0.001	−22.088	−6.449
Presence of tender joints, yes	−8.333	3.388	−2.460	0.015	−15.010	−1.657
Corticosteroids	−7.758	2.581	−3.006	0.003	−12.844	−2.671
Total pain (VAS)	−0.848	0.353	−2.404	0.017	−1.544	−0.153
Anxiety (GAD-7 ≥ 10 score)	−13.452	6.102	−2.204	0.029	−25.477	−1.426

VAS: visual analog scale; PHQ-9: patient health questionnaire; GAD-7: generalized anxiety disorder; SF-36: the Short Form 36 Health Survey; PCS: physical components summary; MCS: mental components summary
p values were obtained with stepwise multiple linear regression analysisanalysis
P numbers of entries with significance are shown in italics

ISSN: 1471-2474